Why is type 1 diabetes uncommon in Asia?

被引:55
|
作者
Park, Yongsoo
机构
[1] Hanyang Univ Hosp, Coll Med, Dept Internal Med, Div Endocrinol & Metab, Kyunggido 471020, South Korea
[2] Hanyang Univ, Coll Engn, Dept Bioengn, Seoul 471020, South Korea
关键词
type; 1; diabetes; incidence; genetic determinants; environmental etiologies;
D O I
10.1196/annals.1375.005
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
T1D (type 1 diabetes) incidence rates are extremely low in Asian populations. The prevalences of islet-specific autoantibodies are reported to be low compared with Caucasians. Although the clinical and immunologic characteristics of T1D in Asians appear to be different from those of Caucasians, if we apply correct patient definition and standardized methods, the typical T1D patients are very similar, in the immunologic as well as genetic perspectives. Although the association of individual allele seems to be different between populations, if we compare the identical DR-DQ haplotypes, the association and transmission to diabetic offspring were similar for Asians and Caucasians. The high-risk HLA genotypes/haplotypes were found to be independent determinants of diabetes in the first-degree relatives of individuals with T1D, particularly in the presence of autoantibodies. A different genetic susceptibility including a low frequency of high-riskHLA alleles could explain the lower prevalence of islet-specific autoantibodies and the low incidence of T1D, or different genetic and environmental interactions might be involved in the etiology of T1D. It is certain that DR-DQ linkage disequilibrium (LD) is an important factor explaining the difference in T1D incidence in different countries. LD between highly susceptible DRB1 alleles and protective DQB1 alleles, and vice versa, is the major contributing factor to the low incidence of T1D in Asians. We also suggested that different genetic/environmental interactions might operate in the etiology of T1D between Caucasians and Asians. It would be of great help for primary prevention to investigate to what degree genetic determinants influence the well-known regional differences in incidences, since we can identify environmental risk factors that may either initiate the autoimmune process or promote already ongoing beta cell damage in different countries. For this, population-based epidemiological studies are necessary to identify risk determinants that may be useful for primary prevention strategies.
引用
收藏
页码:31 / 40
页数:10
相关论文
共 50 条
  • [41] Type 2 diabetes: An epidemic or not, and why it is happening
    Sicree, Richard
    Shaw, Jonathan
    DIABETES & METABOLIC SYNDROME-CLINICAL RESEARCH & REVIEWS, 2007, 1 (02) : 75 - 81
  • [42] Why Treatment Fails in Type 2 Diabetes
    Rosengren, Anders
    Jing, Xingjun
    Eliasson, Lena
    Renstroem, Erik
    PLOS MEDICINE, 2008, 5 (10) : 1426 - 1427
  • [43] Anophthalmia: An Uncommon Manifestation of Neurofibromatosis Type 1
    Chen, Sheng
    Pu, Jia-Li
    Zhang, Jian-Min
    Hong, Yuan
    JOURNAL OF CRANIOFACIAL SURGERY, 2011, 22 (06) : E47 - E48
  • [44] "Mummy, Why Do I Have Diabetes?": A Tangible Interface For Educating Children With Type-1 Diabetes
    Kyfonidis, Charalampos
    Lennon, Marilyn
    PROCEEDINGS OF THE 15TH INTERNATIONAL CONFERENCE ON INTERACTION DESIGN AND CHILDREN (IDC2016), 2016, : 524 - 528
  • [45] Epidemiology and determinants of type 2 diabetes in south Asia
    Hills, Andrew P.
    Arena, Ross
    Khunti, Kamlesh
    Yajnik, Chittaranjan Sakerlal
    Jayawardena, Ranil
    Henry, Christiani Jeyakumar
    Street, Steven J.
    Soares, Mario J.
    Misra, Anoop
    LANCET DIABETES & ENDOCRINOLOGY, 2018, 6 (12): : 966 - 978
  • [46] Clinical management of type 2 diabetes in south Asia
    Misra, Anoop
    Sattar, Naveed
    Tandon, Nikhil
    Shrivastava, Usha
    Vikram, Naval K.
    Khunti, Kamlesh
    Hills, Andrew P.
    LANCET DIABETES & ENDOCRINOLOGY, 2018, 6 (12): : 979 - 991
  • [47] Presumption of innocence for beta cells: why are they vulnerable autoimmune targets in type 1 diabetes?
    Mallone, Roberto
    Eizirik, Decio L.
    DIABETOLOGIA, 2020, 63 (10) : 1999 - 2006
  • [48] Why pumps? Continuous subcutaneous insulin infusion for children and adolescents with type 1 diabetes
    Weintrob, N
    Shalitin, S
    Phillip, M
    ISRAEL MEDICAL ASSOCIATION JOURNAL, 2004, 6 (05): : 271 - 275
  • [49] The early detection of atherosclerosis in type 1 diabetes: why, how and what to do about it
    Jenkins, Alicia
    Januszewski, Andrzej
    O'Neal, David
    CARDIOVASCULAR ENDOCRINOLOGY & METABOLISM, 2019, 8 (01): : 14 - 27
  • [50] Why does the immune system destroy pancreatic β-cells but not α-cells in type 1 diabetes?
    Decio L. Eizirik
    Florian Szymczak
    Roberto Mallone
    Nature Reviews Endocrinology, 2023, 19 : 425 - 434